CID 16197530

T t g g g g g g t t

Structural Information

Molecular Formula
C100H126N38O56P10S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=O)(OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=O)(O)O)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)S)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)O
InChI
InChI=1S/C100H126N38O56P10S9/c1-35-15-129(97(150)125-81(35)140)59-5-39(139)49(176-59)19-167-196(157,205)187-41-7-61(131-17-37(3)83(142)127-99(131)152)178-51(41)21-169-199(160,208)189-43-9-63(133-29-107-69-75(133)113-91(101)119-85(69)144)181-54(43)24-171-201(162,210)191-45-11-65(135-31-109-71-77(135)115-93(103)121-87(71)146)183-56(45)26-173-203(164,212)193-47-13-67(137-33-111-73-79(137)117-95(105)123-89(73)148)185-58(47)28-175-204(165,213)194-48-14-68(138-34-112-74-80(138)118-96(106)124-90(74)149)184-57(48)27-174-202(163,211)192-46-12-66(136-32-110-72-78(136)116-94(104)122-88(72)147)182-55(46)25-172-200(161,209)190-44-10-64(134-30-108-70-76(134)114-92(102)120-86(70)145)180-53(44)23-170-198(159,207)188-42-8-62(132-18-38(4)84(143)128-100(132)153)179-52(42)22-168-197(158,206)186-40-6-60(177-50(40)20-166-195(154,155)156)130-16-36(2)82(141)126-98(130)151/h15-18,29-34,39-68,139H,5-14,19-28H2,1-4H3,(H,157,205)(H,158,206)(H,159,207)(H,160,208)(H,161,209)(H,162,210)(H,163,211)(H,164,212)(H,165,213)(H,125,140,150)(H,126,141,151)(H,127,142,152)(H,128,143,153)(H2,154,155,156)(H3,101,113,119,144)(H3,102,114,120,145)(H3,103,115,121,146)(H3,104,116,122,147)(H3,105,117,123,148)(H3,106,118,124,149)
InChIKey
XIFDGLOQTYNFHK-UHFFFAOYSA-N
Compound name
[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[hydroxy-[[3-[hydroxy-[[3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-sulfanylphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

3352.3042 Da
Monoisotopic Mass

-7.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3353.3115 300.1
[M+Na]+ 3375.2934 302.7
[M-H]- 3351.2969 300.6
[M+NH4]+ 3370.3380 301.1
[M+K]+ 3391.2674 301.3
[M+H-H2O]+ 3335.3015 300.3
[M+HCOO]- 3397.3024 301.2
[M+CH3COO]- 3411.3181 301.5
[M+Na-2H]- 3373.2789 303.6
[M]+ 3352.3037 302.4
[M]- 3352.3047 302.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.